|
ES2217967B1
(es)
*
|
2003-03-31 |
2006-01-01 |
Consejo Sup. Investig. Cientificas |
Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
|
|
US8206950B2
(en)
*
|
2003-06-09 |
2012-06-26 |
Animal Technology Institute Taiwan |
Fusion antigen used as vaccine and method of making them
|
|
US8992939B2
(en)
|
2003-07-11 |
2015-03-31 |
Novavax, Inc. |
Highly efficient influenza matrix (M1) proteins
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US8551756B2
(en)
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
US8506967B2
(en)
|
2003-07-11 |
2013-08-13 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
ES2307346B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
ES2307345B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
DK1778836T3
(da)
*
|
2004-08-19 |
2010-11-22 |
Univ Cardiff |
Fremstilling af antigenpræsenterende humane gammadelta-T-celler og anvendelse ved immunterapi
|
|
US20090208517A1
(en)
*
|
2004-08-19 |
2009-08-20 |
Bernhard Moser |
Preparation Of Antigen-Presenting Human Gamma-Delta T Cells And Use In Immunotherapy
|
|
EP1858332A4
(en)
*
|
2005-02-16 |
2011-06-22 |
Lentigen Corp |
LENTIVIRUS VECTORS AND ITS USE
|
|
ES2570758T3
(es)
|
2005-04-21 |
2016-05-20 |
Univ Florida |
Materiales y métodos para el control de enfermedades respiratorias en cánidos
|
|
ES2310062B1
(es)
*
|
2005-07-15 |
2009-11-13 |
Bionostra, S.L. |
Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
|
|
US8338173B2
(en)
*
|
2005-08-11 |
2012-12-25 |
University College Cardiff Consultants Limited |
Preparation of antigen-presenting human γδ T cells and use in immunotherapy
|
|
BRPI0617486A2
(pt)
*
|
2005-10-18 |
2011-07-26 |
Novavax Inc |
vacina que compreende partÍculas similares a vÍrus da gripe funcionais (vlp) e uso de uma vlp de gripe
|
|
BRPI0617735B1
(pt)
|
2005-10-19 |
2022-05-17 |
University Of Florida Research Foundation Inc |
Composições compreendendo vírus isolados, polinucleotídeos, ou polipeptídeos, construções de expressão, vacinas, kits para proteger um canino da infecção do vírus influenza, uso do vírus na preparação de composição farmacêutica bem como método in vitro para detecção de um vírus influenza que é capaz de infectar um animal canídeo
|
|
WO2008048269A2
(en)
*
|
2005-10-20 |
2008-04-24 |
Combimatrix Corporation |
Microarray for pathogen identification
|
|
GB2432419A
(en)
*
|
2005-11-16 |
2007-05-23 |
Agency Science Tech & Res |
Influenza A virus detection method
|
|
FI20051255A0
(fi)
*
|
2005-12-05 |
2005-12-05 |
Pekka Untamo Heino |
Seuraavaa influenssa A-pandemiaa vastaan soveltuva rokote
|
|
WO2008042450A2
(en)
*
|
2006-01-20 |
2008-04-10 |
Lawrence Livermore National Security, Llc. |
Multiplex detection of respiratory pathogens
|
|
MX2008009929A
(es)
*
|
2006-02-02 |
2008-10-01 |
Globeimmune Inc |
Vacuna a base de levadura para inducir una respuesta inmune.
|
|
GB0613977D0
(en)
*
|
2006-02-07 |
2006-08-23 |
Peptcell Ltd |
Peptide sequences and compositions
|
|
EP2476432B1
(en)
*
|
2006-03-07 |
2015-08-19 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2007126788A2
(en)
*
|
2006-03-27 |
2007-11-08 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the treatment and prevention of viral infection
|
|
US20070243587A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Healthbanks Biotech Co., Ltd. |
Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
|
|
WO2007130327A2
(en)
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Influenza virus-like particle (vlp) compositions
|
|
WO2007130330A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (vlp) compositions
|
|
EP1998814A4
(en)
*
|
2006-05-11 |
2010-06-16 |
Novavax Inc |
NEW VACCINES AGAINST INFLUENZA M2
|
|
KR100702034B1
(ko)
*
|
2006-05-12 |
2007-03-30 |
삼성전자주식회사 |
반도체 장치, 이 장치의 전원 노이즈 감소 방법 및 인쇄회로 기판
|
|
US20100184832A1
(en)
|
2006-07-14 |
2010-07-22 |
Sanofi Pasteur Biologics Co. |
Construction of Recombinant Virus Vaccines by Direct Transposon-Mediated Insertion of Foreign Immunologic Determinants into Vector Virus Proteins
|
|
WO2008094200A2
(en)
*
|
2006-07-27 |
2008-08-07 |
Ligocyte Pharmaceuticals, Inc |
Chimeric virus-like particles
|
|
WO2008094197A2
(en)
|
2006-07-27 |
2008-08-07 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric influenza virus-like particles
|
|
US20090098527A1
(en)
*
|
2006-09-12 |
2009-04-16 |
Fischer Gerald W |
Biological organism identification product and methods
|
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
ES2618885T3
(es)
|
2006-09-29 |
2017-06-22 |
Takeda Vaccines, Inc. |
Formulaciones de vacuna para norovirus
|
|
WO2008100290A2
(en)
|
2006-09-29 |
2008-08-21 |
Sanofi Pasteur Biologics Co |
Recombinant rhinovirus vectors
|
|
WO2008058396A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Folia Biotech Inc. |
Papaya mosaic virus-based vaccines for influenza
|
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
WO2009012487A2
(en)
*
|
2007-07-19 |
2009-01-22 |
Novavax, Inc. |
Chimeric varicella zoster virus-virus like particles
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
EP3058954B1
(en)
|
2007-08-27 |
2017-03-01 |
Longhorn Vaccines and Diagnostics, LLC |
Immunogenic compositions and methods
|
|
US20100266636A1
(en)
|
2007-09-18 |
2010-10-21 |
Ligocyte Pharmaceuticals, Inc. |
Method of conferring a protective immune response to norovirus
|
|
KR20100083150A
(ko)
|
2007-09-18 |
2010-07-21 |
리고사이트 파머슈티컬즈 인코퍼레이티드 |
노로바이러스에 대한 보호면역반응을 제공하는 방법
|
|
ES2552858T3
(es)
*
|
2007-10-01 |
2015-12-02 |
Longhorn Vaccines And Diagnostics, Llc |
Recogida de muestras biológicas y sistema de transporte y métodos de uso
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
CN103122354B
(zh)
|
2007-11-27 |
2018-03-23 |
麦迪卡格公司 |
表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp)
|
|
KR101956910B1
(ko)
*
|
2008-01-21 |
2019-03-12 |
메디카고 인코포레이티드 |
헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
|
|
WO2009102229A1
(ru)
*
|
2008-02-15 |
2009-08-20 |
A.N. Belozersky Institute Of Physico-Chemical Biology, Moscow State University |
Липид-протеиновый рафтовый комплекс из оболочки вируса гриппа а для противогриппозных вакцин и способ его выделения, способ получения вирусоподобных частиц из таких комплексов
|
|
WO2009129227A1
(en)
|
2008-04-17 |
2009-10-22 |
Pds Biotechnology Corporation |
Stimulation of an immune response by enantiomers of cationic lipids
|
|
SG190562A1
(en)
|
2008-04-18 |
2013-06-28 |
Vaxinnate Corp |
Deletion mutants of flagellin and methods of use
|
|
US8486619B2
(en)
*
|
2008-05-02 |
2013-07-16 |
University Of Rochester |
Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses
|
|
WO2010036400A2
(en)
*
|
2008-05-02 |
2010-04-01 |
University Of Rochester |
Arrayed detector system for measurement of anti-viral immune response
|
|
CN101293099B
(zh)
*
|
2008-06-04 |
2010-12-08 |
厦门大学 |
一种抗多种亚型禽流感病毒的多肽疫苗及其制备方法
|
|
US8771703B2
(en)
|
2008-07-08 |
2014-07-08 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
AU2009270404B2
(en)
*
|
2008-07-18 |
2015-01-29 |
Medicago Inc. |
New influenza virus immunizing epitope
|
|
US20110206727A1
(en)
*
|
2008-07-30 |
2011-08-25 |
Denis Leclerc |
Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
|
|
IT1394782B1
(it)
|
2009-03-03 |
2012-07-13 |
Alenia Aeronautica Spa |
Procedimento di predizione di collisioni tra un velivolo e un aeromobile
|
|
EP2413962A1
(en)
*
|
2009-03-30 |
2012-02-08 |
Mount Sinai School of Medicine |
Influenza virus vaccines and uses thereof
|
|
AU2010243489A1
(en)
*
|
2009-05-01 |
2011-12-22 |
Redbiotec Ag |
Recombinant virus-like particles encoded by multi-gene vector
|
|
AU2010254136B2
(en)
*
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
CA2762042C
(en)
|
2009-06-24 |
2012-11-20 |
Medicago Inc. |
Chimeric influenza virus-like particles comprising hemagglutinin
|
|
CA2766899C
(en)
|
2009-07-02 |
2021-05-04 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
|
HRP20171564T1
(hr)
|
2009-09-22 |
2017-11-17 |
Medicago Inc. |
Postupak za pripremu biljnih čestica sličnih virusu (vlp)
|
|
US20110097358A1
(en)
*
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
WO2011056899A2
(en)
|
2009-11-03 |
2011-05-12 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
|
|
US9352031B2
(en)
|
2010-02-18 |
2016-05-31 |
Technovax, Inc. |
Universal virus-like particle (VLP) influenza vaccines
|
|
AU2011217903B2
(en)
|
2010-02-18 |
2017-03-02 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
US20110305748A1
(en)
|
2010-03-11 |
2011-12-15 |
Immune Design, Corp. |
Vaccines for Pandemic Influenza
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
MX2012011300A
(es)
|
2010-03-30 |
2012-11-29 |
Sinai School Medicine |
Vacunas del virus de influenza y usos de las mismas.
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CN102373182A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性囊病混合病毒样颗粒、制备方法和应用
|
|
CN102373184A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用
|
|
JP2013541528A
(ja)
|
2010-09-21 |
2013-11-14 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
|
|
EP3431485B2
(en)
|
2010-10-01 |
2024-09-04 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
|
PT2635257T
(pt)
*
|
2010-11-05 |
2017-08-16 |
Novavax Inc |
Partículas semelhantes a vírus de glicoproteína de raiva (vlps)
|
|
TWI526539B
(zh)
*
|
2010-12-22 |
2016-03-21 |
苜蓿股份有限公司 |
植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
|
|
WO2012088428A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Novavax Inc. |
Modified influenza hemagglutinin proteins and uses thereof
|
|
TWI620816B
(zh)
|
2011-03-23 |
2018-04-11 |
苜蓿股份有限公司 |
植物衍生蛋白回收方法
|
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
|
JP6113155B2
(ja)
|
2011-06-20 |
2017-04-12 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
計算で最適化した広い反応性を示すｈ１ｎ１インフルエンザの抗原
|
|
HK1199202A1
(en)
|
2011-07-11 |
2015-06-26 |
武田疫苗股份有限公司 |
Parenteral norovirus vaccine formulations
|
|
CN103945863A
(zh)
|
2011-08-01 |
2014-07-23 |
爱默蕾大学 |
包含配体的vlp及其相关方法
|
|
EP2739307B1
(en)
|
2011-08-01 |
2017-09-06 |
Emory University |
Vlps containing ligands and methods related thereto
|
|
JP2014527799A
(ja)
|
2011-08-26 |
2014-10-23 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
IN2014CN02114A
(enExample)
|
2011-09-20 |
2015-05-29 |
Sinai School Medicine |
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
EP3494989B1
(en)
|
2012-01-26 |
2025-07-16 |
Longhorn Vaccines and Diagnostics, LLC |
Composite antigenic sequences and vaccines
|
|
RU2018113521A
(ru)
|
2012-02-07 |
2019-03-04 |
Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн |
Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b
|
|
EP3305806B1
(en)
|
2012-02-13 |
2020-08-26 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
|
|
RU2485973C1
(ru)
*
|
2012-02-28 |
2013-06-27 |
Общество с ограниченной ответственностью "НТфарма" |
Рекомбинантная трехвалентная вакцина от гриппа человека
|
|
IN2014DN07152A
(enExample)
|
2012-03-22 |
2015-04-24 |
Fraunhofer Usa Inc |
|
|
CA2868330A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
WO2013177294A1
(en)
*
|
2012-05-22 |
2013-11-28 |
Cornell University |
Reagents and methods for identifying anti-hiv compounds
|
|
CN105163753B
(zh)
|
2012-06-15 |
2018-12-21 |
Pds生物科技公司 |
阳离子脂质疫苗组合物和使用方法
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|
|
EP2897639A4
(en)
*
|
2012-09-21 |
2016-05-04 |
Frank Bedu-Addo |
IMPROVED VACCINATE COMPOSITIONS AND METHODS OF USE
|
|
KR101484588B1
(ko)
|
2012-10-24 |
2015-01-20 |
대한민국 |
개 인플루엔자 ｖｌｐ 백신의 제조방법
|
|
CA2892529C
(en)
|
2012-11-26 |
2023-04-25 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
SG11201503989PA
(en)
|
2012-11-27 |
2015-06-29 |
Univ Pittsburgh |
Computationally optimized broadly reactive antigens for h1n1 influenza
|
|
EP4154907A1
(en)
|
2012-12-18 |
2023-03-29 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP6553033B2
(ja)
|
2013-08-13 |
2019-07-31 |
ノースウェスタン ユニバーシティ |
ペプチドコンジュゲート粒子
|
|
CN103467581B
(zh)
*
|
2013-08-26 |
2016-01-20 |
中国科学院微生物研究所 |
流感病毒m1蛋白及其编码基因和应用
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
|
EP3092309B1
(en)
|
2014-01-10 |
2021-02-24 |
Medicago Inc. |
Cpmv enhancer elements
|
|
DK4023249T3
(da)
|
2014-04-23 |
2025-01-13 |
Modernatx Inc |
Nukleinsyrevacciner
|
|
US11273127B2
(en)
|
2014-05-06 |
2022-03-15 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for thermally stable multi-targeted antigens
|
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
JP6602762B2
(ja)
*
|
2014-07-18 |
2019-11-06 |
Ｋｍバイオロジクス株式会社 |
ウイルス様粒子を含むワクチン
|
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
|
KR101745472B1
(ko)
|
2015-04-15 |
2017-06-12 |
대한민국 |
조류인플루엔자 바이러스의 세포 감염을 저해하는 물질을 선별하는 방법
|
|
CA2985652C
(en)
|
2015-05-14 |
2020-03-10 |
Gerald W. FISHER |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
JP2018530314A
(ja)
|
2015-08-28 |
2018-10-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ウイルス様粒子からの感染性インフルエンザウイルスの生成
|
|
US10426829B2
(en)
|
2015-09-03 |
2019-10-01 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
WO2017044890A1
(en)
*
|
2015-09-10 |
2017-03-16 |
Academia Sinica |
Bird flu vaccine combination comprising virus-like particles and novel adjuvants
|
|
CA3005251A1
(en)
|
2015-11-13 |
2017-05-18 |
Pds Biotechnology Corporation |
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
|
|
WO2017143236A1
(en)
|
2016-02-19 |
2017-08-24 |
Yoshihiro Kawaoka |
Improved influenza b virus replication for vaccine development
|
|
WO2017218624A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
WO2018213731A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
|
|
WO2019023811A1
(en)
|
2017-08-04 |
2019-02-07 |
The Hospital For Sick Children |
NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY
|
|
CN107353328A
(zh)
*
|
2017-08-23 |
2017-11-17 |
上海市动物疫病预防控制中心 |
一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途
|
|
CN107488216B
(zh)
*
|
2017-09-06 |
2020-11-10 |
中国人民解放军军事医学科学院微生物流行病研究所 |
一种流感病毒通用疫苗及其制备方法与应用
|
|
US11197926B2
(en)
|
2017-10-25 |
2021-12-14 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
|
CN110240634B
(zh)
*
|
2018-03-08 |
2022-09-06 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
CN110575538B
(zh)
*
|
2018-06-11 |
2022-08-19 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
EP3810634A4
(en)
|
2018-06-21 |
2022-07-27 |
Icahn School of Medicine at Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
JP7783047B2
(ja)
|
2018-08-07 |
2025-12-09 |
ウィスコンシン アルムニ リサーチ ファンデイション |
組換えの生物学的に封じ込められたフィロウイルスワクチン
|
|
JP7655849B2
(ja)
|
2018-08-20 |
2025-04-02 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
|
|
CN109097341B
(zh)
*
|
2018-08-28 |
2021-09-24 |
青岛农业大学 |
一种同时表达ha和hef的复制缺陷型重组流感病毒
|
|
CN111315407B
(zh)
|
2018-09-11 |
2023-05-02 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
|
EP3921413A1
(en)
|
2019-02-08 |
2021-12-15 |
Wisconsin Alumni Research Foundation (WARF) |
Humanized cell line
|
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
CN113461786B
(zh)
*
|
2020-03-30 |
2022-09-13 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
CN113398259A
(zh)
*
|
2021-04-30 |
2021-09-17 |
吉林大学 |
一种h9n2亚型禽流感新型标记疫苗的制备方法及其应用
|
|
CN113403343A
(zh)
*
|
2021-04-30 |
2021-09-17 |
吉林大学 |
一种h3n2与h9n2亚型禽流感二价嵌合型病毒样颗粒的制备
|